Get started
Author

Adrián Sousa

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis
2014 · Maureen D. Mayes, Lara Bossini-Castillo, et al. · The American Journal of Human Genetics · 218
PDF
Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae
2018 · Adrian Sousa, María Teresa Pérez-Rodríguez, et al. · Journal of Antimicrobial Chemotherapy · 149
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)
2022 · Juan José Castón, Angela Cano, et al. · Journal of Antimicrobial Chemotherapy · 81
Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score
2017 · Javier Cobo, Esperanza Merino, et al. · International Journal of Antimicrobial Agents · 60
Clinical peculiarities of patients with scleroderma exposed to silica: A systematic review of the literature
2015 · Mayka Freire, María Alonso, et al. · Seminars in Arthritis and Rheumatism · 51
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
2023 · Sara Grillo, Miquel Pujol, et al. · Nature Medicine · 49
PDF
Short- versus long-course therapy in gram-negative bacilli bloodstream infections
2019 · Adrian Sousa, María Teresa Pérez-Rodríguez, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 45
Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort
2020 · Federica Calò, Pilar Retamar, et al. · Journal of Antimicrobial Chemotherapy · 42
Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis
2023 · Milagros Suárez, Antonio Pérez-Landeiro, et al. · International Journal of Infectious Diseases · 33
PDF
Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
2022 · O. Lima, A. Sousa, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 27
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
2020 · David González-Serna, Eguzkine Ochoa, et al. · Scientific Reports · 27
The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia
2020 · M. Teresa Pérez-Rodríguez, Adrián Sousa, et al. · International Journal of Infectious Diseases · 22
PDF
Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality inStaphylococcus aureusbacteraemia
2019 · María Teresa Pérez-Rodríguez, Adrián Sousa, et al. · Journal of Antimicrobial Chemotherapy · 22
PDF
Influenza a Virus Infection is associated with Systemic Capillary Leak Syndrome: Case Report and Systematic Review of the Literature
2015 · Adrian Sousa, Oscar Len, et al. · Antiviral Therapy · 20
Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis
2020 · Laura Escolà-Vergé, Guillermo Cuervo, et al. · Clinical Microbiology and Infection · 17
Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia
2021 · O. Lima Rodríguez, A. Sousa, et al. · Medicine · 16
Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease
2017 · Adrian Sousa, Maria Teresa Pérez-Rodríguez, et al. · Enfermedades Infecciosas y Microbiología Clínica · 16
Risk of cardiac device-related infection in patients with late-onset bloodstream infection. Analysis on a National Cohort
2022 · Lucía Boix-Palop, Beatriz Dietl, et al. · Journal of Infection · 14
Infections after spine instrumentation: effectiveness of short antibiotic treatment in a large multicentre cohort
2020 · Eva Benavent, Dolors Rodríguez-Pardo, et al. · Journal of Antimicrobial Chemotherapy · 14
Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC
2024 · Sandra De la Rosa-Riestra, Pedro María Martínez Pérez-Crespo, et al. · International Journal of Infectious Diseases · 13
Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a β-lactamase producing organism
2018 · Adrian Sousa, María Teresa Pérez-Rodríguez, et al. · Scandinavian Journal of Infectious Diseases · 13
Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study
2024 · Mariana Guedes, David Gathara, et al. · Annals of Clinical Microbiology and Antimicrobials · 10
A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study
2024 · Sandra De la Rosa-Riestra, Inmaculada López-Hernández, et al. · Journal of Antimicrobial Chemotherapy · 9
Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
2023 · M. Ávila-Núñez, O. Lima, et al. · Annals of Clinical Microbiology and Antimicrobials · 9
PDF
Successful ceftazidime–avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis
2022 · Olalla Lima, Adrián Sousa, et al. · Infection · 7
Works count: 50
Citation count: 1,019
H-index: 16
I10-index: 22
Year
Topic
Type